vyvanse 50 mg
medison pharma ltd - lisdexamfetamine dimesylate - capsules - lisdexamfetamine dimesylate 50 mg - lisdexamfetamine - vyvanse is a central nervous system (cns) stimulant indicated for the treatment of attention deficit hyperactivity disorder (adhd) in patients ages 6 years and above.vyvanse is indicated for the treatment of moderate to severe binge eating disorder (bed) for patient over 18 years.limitation of use:vyvanse is not indicated or recommended for weight loss. use of other sympathomimetic drugs for weight loss has been associated with serious cardiovascular adverse events. the safety and effectiveness of vyvanse for the treatment of obesity have not been established
vyvanse 70 mg
medison pharma ltd - lisdexamfetamine dimesylate - capsules - lisdexamfetamine dimesylate 70 mg - lisdexamfetamine - vyvanse is a central nervous system (cns) stimulant indicated for the treatment of attention deficit hyperactivity disorder (adhd) in patients ages 6 years and above.vyvanse is indicated for the treatment of moderate to severe binge eating disorder (bed) for patient over 18 years.limitation of use:vyvanse is not indicated or recommended for weight loss. use of other sympathomimetic drugs for weight loss has been associated with serious cardiovascular adverse events. the safety and effectiveness of vyvanse for the treatment of obesity have not been established
vyvanse capsules 20 mg
takeda pharmaceuticals (asia pacific) pte. ltd. - lisdexamfetamine dimesylate - capsule - lisdexamfetamine dimesylate 20.0 mg
vyvanse capsules 30 mg
takeda pharmaceuticals (asia pacific) pte. ltd. - lisdexamfetamine dimesylate - capsule - lisdexamfetamine dimesylate 30.0 mg
vyvanse capsules 40 mg
takeda pharmaceuticals (asia pacific) pte. ltd. - lisdexamfetamine dimesylate - capsule - lisdexamfetamine dimesylate 40.0 mg
vyvanse capsules 50 mg
takeda pharmaceuticals (asia pacific) pte. ltd. - lisdexamfetamine dimesylate - capsule - lisdexamfetamine dimesylate 50.0 mg
vyvanse capsules 60 mg
takeda pharmaceuticals (asia pacific) pte. ltd. - lisdexamfetamine dimesylate - capsule - lisdexamfetamine dimesylate 60.0 mg
vyvanse capsules 70 mg
takeda pharmaceuticals (asia pacific) pte. ltd. - lisdexamfetamine dimesylate - capsule - lisdexamfetamine dimesylate 70.0 mg
elvanse 20 mg hard caps.
takeda pharmaceuticals international ireland branch ag - lisdexamfetamine dimesylate 20 mg - eq. dexamfetamine 5,9 mg - capsule, hard - 20 mg - lisdexamfetamine dimesylate 20 mg - lisdexamfetamine
elvanse 30 mg hard caps.
takeda pharmaceuticals international ireland branch ag - lisdexamfetamine dimesylate 30 mg - eq. dexamfetamine 8,9 mg - capsule, hard - 30 mg - lisdexamfetamine dimesylate 30 mg - lisdexamfetamine